- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Sep 19, 2024
842695062267385IT-MF-000009277Certificate health across this manufacturer's portfolio.
V12 034483 0002Issued1 warning recorded — scroll inside the panel to see all entries.
CW129Primary placement in Italy; available across 17 countries total.
| Country | On market since | Until |
|---|---|---|
| ItalyPrimary placement | Sep 18, 2024 | Still on market |
| Austria | Sep 18, 2024 | Still on market |
| Belgium | Sep 18, 2024 | Still on market |
| Cyprus | Sep 18, 2024 | Still on market |
| Germany | Sep 18, 2024 | Still on market |
| EL | Sep 18, 2024 | Still on market |
| Spain | Sep 18, 2024 | Still on market |
| Croatia | Sep 18, 2024 | Still on market |
| Ireland | Sep 18, 2024 | Still on market |
| Liechtenstein | Sep 18, 2024 | Still on market |
| Lithuania | Sep 18, 2024 | Still on market |
| Luxembourg | Sep 18, 2024 | Still on market |
| Malta | Sep 18, 2024 | Still on market |
| Netherlands | Sep 18, 2024 | Still on market |
| Poland | Sep 18, 2024 | Still on market |
| Romania | Sep 18, 2024 | Still on market |
| XI | Sep 18, 2024 | Still on market |
European Medical Device Nomenclature — the EU product classification assigned to this device.
W01010213GLUCOSE